Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Plasmacytoma
ADR ID BADD_A03443
ADR Hierarchy
01      Blood and lymphatic system disorders
01.14      Plasma cell neoplasms
01.14.02      Plasma cell myelomas
01.14.02.002      Plasmacytoma
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.23      Plasma cell neoplasms
16.23.02      Plasma cell myelomas
16.23.02.002      Plasmacytoma
Description Any discrete, presumably solitary, mass of neoplastic PLASMA CELLS either in BONE MARROW or various extramedullary sites. [MeSH]
MedDRA Code 10035484
MeSH ID D010954
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Neoplasm of uncertain behavior of plasma cells | Neoplasm of uncertain behaviour of plasma cells | Plasma cell tumor | Plasmacytoma | Extramedullary plasmacytoma | Plasma cell tumour | Plasmacytomas | Plasmocytoma | Plasmocytomas | Plasma Cell Tumor | Plasma Cell Tumors | Tumor, Plasma Cell | Tumors, Plasma Cell
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00284Bortezomib0.000616%
BADD_D00367Carfilzomib0.000336%
BADD_D00497Clomiphene--
BADD_D00623Dexamethasone0.000509%
BADD_D00680Dimethyl fumarate0.000600%
BADD_D00723Doxorubicin0.000168%
BADD_D01119Ibrutinib0.000112%
BADD_D01136Imatinib0.000112%
BADD_D01250Lasofoxifene--
BADD_D01253Lenalidomide0.017095%
BADD_D01376Melphalan--
BADD_D01662Pamidronic acid--
BADD_D01798Pomalidomide0.007450%
BADD_D01818Pramipexole dihydrochloride--
BADD_D01834Prednisone0.000018%
BADD_D01858Propagermanium--
BADD_D01978Ruxolitinib--
BADD_D02007Semaxanib--
BADD_D02105Tacrolimus0.000446%
BADD_D02165Teriflunomide0.000241%
BADD_D02192Thalidomide0.001133%
BADD_D02346Venlafaxine--
BADD_D02392Zoledronic acid--
The 1th Page    1    Total 1 Pages